The investment is part of a 5-year plan to invest $10 billion in Canadian communities by 2030BRAMPTON, Ontario, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Today, Loblaw Companies Limited (TSX: L, “Loblaw” or the “Company”), Canada’s food and pharmacy leader, announced that it will spend $2.4 billion in 2026 to expand and renovate its store network, enhance its supply chain capabilities, and create jobs for people all across Canada. At a time when Canadians are struggling with affordability and access to healthcare s ...

WALTHAM, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in a webcast fireside chat at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 9:50 a.m. ET. The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 30 days following the event. About Apelli ...

Ocular to present detailed SOL-1 data at the 49th Macula Society Annual Meeting on Friday, February 27, 2026, starting at 1:00 PM PT (4:00 PM ET) Company to host an investor webcast on Monday, March 2, 2026, at 7:30 AM ET to discuss the Macula Society presentations BEDFORD, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that the Company will present detailed re ...

TORONTO and NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX:ILLM, OTCQB:ILLMF) (“illumin” or “Company”), a leader in digital advertising technology that empowers marketers to make smarter decisions about communicating with online consumers, announces that it will report its fourth quarter and year-end 2025 financial results before market open on Friday, March 13, 2026. Investors and analysts are invited to join a live webcast on Friday, March 13, 2026, at 8:30 AM ET, where CEO Simon C ...

Press Release February 23, 2026 Signify share repurchase periodic update Eindhoven, The Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced that it has repurchased 139,500 shares in the period February 13 to February 20, 2026. The shares were repurchased at an average price of EUR 20.06 per share and an aggregate amount of EUR 2.8 million. The repurchases were made as part of the company’s share repurchase program, which was announced on 13 February 2026. Details on the ...

European client will utilize PyroGenesis’ titanium powder in electron beam melting applicationsMONTREAL, Feb. 23, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), the leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today the signing of a contract with a Scientific Aerospace Research Organization for the supply of titanium metal powder produced by PyroGenesis’ N ...

ROUYN-NORANDA, Canada, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Abcourt Mines Inc. ("Abcourt" or the "Company") (TSX Venture: ABI) (OTCQB: ABMBF) is pleased to announce that the high-resolution drone magnetic survey undertaken in early January on the Flordin property has been completed and results are now available. Highlights: The main east-SE/west-NW strike magnetic anomaly is continuous over the entire property and corresponds, according to known geological information, to the mafic lava sequence (basalt-andes ...

WARREN, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, announced today that the management team will participate in the upcoming Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25-26, which is a virtual event. The Aquestive team will be presenting on February 26th, at 1 ...

Highlights Assay results reported for a further 13 drill holes for 4,965m of infill & expansion diamond drilling. Notable, selected drill intercepts from the holes include: HM112: 602m @ 0.32% CuEq incl. 272m @ 0.44% CuEq incl. 40m @ 0.50% CuEq HM121: 495m @ 0.31% CuEq incl. 284m @ 0.42% CuEq HM117: 184m @ 0.51% CuEq (12 - 196m) incl. 16m @ 1.09% CuEq16m @ 0.46% CuEq (268 - 284m)30m @ 0.51% CuEq (300 - 330m) HM111: 64m @ 0.42% CuEq (154 - 218m) incl. 6m @ 0.74% CuEq HM114: 66m @ 0.40% CuEq (28 - ...

-Interim clinical study results for the BB-301 Phase 1b/2a Treatment Study including 12-month follow-up results for the first four Cohort 1 completers, 24-month clinical study results for the first Cohort 1 Patient, and interim clinical study results for the first Cohort 2 Patient will be reported in a late-breaking poster presentation at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference on March 9, 2026- HAYWARD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDA ...